Control of Oral Anticoagulant Therapy with Whole Blood Prothrombin Time Devices: the Future Has Begun

Armando Tripodi

doi:10.1055/s-0037-1614028

Thrombosis and Haemostasis, Inhaltsverzeichnis

Thromb Haemost 2000; 84(03): 362-363
DOI: 10.1055/s-0037-1614028

Commentary

Schattauer GmbH

Control of Oral Anticoagulant Therapy with Whole Blood Prothrombin Time Devices: the Future Has Begun

Autor*innen

Armando Tripodi

¹From the Angelo Bianchi Bonomi Hemophilia and Thrombosis Centre, Department of Internal Medicine, University and IRCCS Maggiore Hospital, Milano, Italy

Abstract

Volltext

Referenzen

References
1 Lucas FV, Duncan A, Jay R, Coleman R, Craft P, Chan B, Winfrey L, Mungall DR, Hirsh J. A novel whole blood capillary technique for measuring the prothrombin time. Am J Clin Pathol 1987; 88: 442-6.
2 Ansell J, Holden A, Knapic RN. Patient self management of oral anticoagulation guided by a capillary (fingerstick) whole blood prothrombin times. Arch Int Med 1989; 149: 2509-11.
3 White RH, Mc SACurdy, von Marensdorff H, Woodruff Jr DE, Leftgoff L. Home prothrombin time monitoring after initiation of warfarin therapy. Ann Int Med 1989; 111: 730-7.
4 Poller L, Schiach CR, MacCallum PK, Johansen AM, Munster AM, Magalhaes A, Jespersen J. The European Concerted Action on Anticoagulation (ECAA) Multicentre randomised study of computerised anticoagulant dosage. The Lancet 1998; 352: 1505-9.
5 Guidelines for thromboplastins and plasma used to control oral anticoagulant therapy. WHO Expert Committee on Biological Standardization. Technical Report Series 889; forty-eight report. Geneva, Switzerland: WHO;
6 Tripodi A, Arbini AA, Chantarangkul V, Bettega D, Mannucci PM. Are capillary whole blood coagulation monitors suitable for the control of oral anticoagulant treatment by the international normalized ratio. Thromb Haemost 1993; 70: 921-4.
7 Tripodi A, Chantarangkul V, Clerici M, Negri B, Mannucci PM. Determination of the International Sensitivity Index of a new near patient testing device to monitor oral anticoagulant therapy Overview on the assessment of conformity to the calibration model. Thromb Haemost 1997; 78: 855-8.
8 Kitchen S, Preston FE. Monitoring oral anticoagulant treatment with the TAS near patient test system: comparison with conventional thromboplastins. J Clin Pathol 1997; 50: 951-956.
9 Poller L, van den Besselaar AMHP, Jespersen J, van der Meer F, Preston FE, Tripodi A. Normalisation and standardisation of home prothrombin time (PT) monitors. Thromb Haemost. (Suppl. August 1999) 548.
10 Van den Besselaar AMHP. A comparison of INRs determined with a whole blood prothrombin time device and two international reference preparations for thromboplastin. Thromb Haemost 2000; 84: 410-2.
11 Anderson DR, Harrison L, Hirsh J. Evaluation of a portable prothrombin time monitor for home use by patients who require long-term oral anticoagulant therapy. Arch Int Med 1993; 153: 1441-7.
12 Douketis JD, Lane A, Milne A, Ginsberg JS. Accuracy of a portable international normalization ratio monitor in outpatients receiving long term oral anticoagulant therapy: comparison with a laboratory reference standard using clinically relevant criteria for agreement. Thromb Res 1998; 92: 11-7.